HM Payson & Co’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-3,507,777
Closed -$88.4M – 1171
2025
Q3
$88.4M Buy
3,507,777
+388,247
+12% +$9.8M 1.27% 24
2025
Q2
$78.5M Sell
3,119,530
-168,187
-5% -$4.22M 1.24% 26
2025
Q1
$82.7M Buy
3,287,717
+245,510
+8% +$6.16M 1.45% 23
2024
Q4
$76.2M Buy
3,042,207
+280,278
+10% +$7.02M 1.29% 23
2024
Q3
$69.3M Buy
2,761,929
+80,739
+3% +$2.01M 1.19% 27
2024
Q2
$66.7M Buy
2,681,190
+173,859
+7% +$4.31M 1.21% 29
2024
Q1
$62.2M Buy
2,507,331
+383,209
+18% +$9.49M 1.16% 29
2023
Q4
$52.6M Buy
2,124,122
+414,869
+24% +$10.2M 1.09% 28
2023
Q3
$41.7M Buy
1,709,253
+1,595,861
+1,407% +$38.9M 0.98% 30
2023
Q2
$2.76M Buy
+113,392
New +$2.78M 0.06% 126
2022
Q4
– Sell
-30,000
Closed -$724K – 964
2022
Q3
$724K Buy
+30,000
New +$740K 0.02% 207

Other funds holding IBDQ

HM Payson & Co's IBDQ Position: Q4 2025 in Review

HM Payson & Co sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 3,507,777 shares — an estimated $88.4M sold.

HM Payson & Co first reported a position in IBDQ in Q3 2022 and held it in 11 quarters. The position peaked at $88.4M in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • HM Payson & Co reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • HM Payson & Co sold 3,507,777 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $88.4M.
  • HM Payson & Co first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2022 and held it in 11 quarters.
  • HM Payson & Co's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $88.4M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on HM Payson & Co's 13F filing for Q4 2025, filed 12 Feb 2026.